CLINICAL_TRIALS
trial_result
· 2021-04-30
Clinical Trial Update: Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics
Summary
A completed clinical trial comparing outcomes of Xeljanz with biologics in patients with rheumatoid arthritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Status: COMPLETED | Results posted: 2021-04-30